We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,171

10 Things You Need to Know About Health Care Bankruptcies in 2017
  • Foley & Lardner LLP
  • USA
  • November 29 2016

The coming year will likely continue to be a tumultuous year for health care providers, suppliers, and payers, as they adapt to meet new challenges


Swearing Behind A Reference With Reasonably Continuous Diligence
  • Foley & Lardner LLP
  • USA
  • November 16 2016

In Perfect Surgical Techniques, Inc. v. Olympus America, Inc., the Federal Circuit vacated and remanded a USPTO Patent Trial and Appeal Board


New Presidency Will Compel Action in Key Areas of Health Care in 2017
  • Foley & Lardner LLP
  • USA
  • November 3 2016

As we enter the final stretch of the U.S. presidential election, health care remains one of the most contested issues with great potential for change


OPPS Final Rule Finalizes Limits for Off Campus Departments
  • Foley & Lardner LLP
  • USA
  • November 3 2016

Center for Medicare and Medicaid Services (CMS) issued the long-awaited implementation of the “site-neutrality” provisions of the H.R. 1314


FTC Again Finds Success in High-Profile Hospital Merger Appeal
  • Foley & Lardner LLP
  • USA
  • November 2 2016

For the second time in recent weeks, the Federal Trade Commission (FTC) prevailed in its challenge of a high-profile hospital merger. This time, the


Seventh Circuit Applies Escobar’s Materiality Standard to (Again) Reject False Certification Claim
  • Foley & Lardner LLP
  • USA
  • October 31 2016

This summer, the United States Supreme Court undertook to resolve the long-running circuit split over the validity and scope of the implied false


Supreme Court Implied False Certification Case Reargued to First Circuit
  • Foley & Lardner LLP
  • USA
  • October 27 2016

On Tuesday, October 25, 2016, a three-judge panel of the United States Court of Appeals for the First Circuit heard argument in United States ex rel


Biogen TYSABRI Patents Spared Inter Partes Review
  • Foley & Lardner LLP
  • USA
  • October 25 2016

The USPTO Patent Trial and Appeals Board (PTAB) declined to institute Inter Partes Review (IPR) proceedings against three Biogen Idec TYSABRI patents


AHCA Sues to Enjoin Prohibition on Binding Arbitration
  • Foley & Lardner LLP
  • USA
  • October 20 2016

On October 4, 2016 CMS issued its Final Rule entitled “Reform of Requirements for Long Term Care Facilities” which updates the requirements for all


New Report Outlines 5 Year Plan to Achieve Cancer Moonshot
  • Foley & Lardner LLP
  • USA
  • October 18 2016

The Cancer Moonshot Task Force has just released its 5 year plan for implementing President Obama’s “Cancer Moonshot” program (“Report”). The